| |
human gene symbol | disease name | chicken gene symbol |
|---|
| VWF | von Willebrand disease, type 1 | VWF | | VWF | von Willebrand disease, types 2A, 2B, 2M, and 2N | VWF | | VWF | von Willibrand disease, type 3 | VWF | | MESP2 | Spondylocostal dysostosis, autosomal recessive 2 | MESP2 | | ZFAT1 | {Autoimmune thyroid disease, susceptibility to, 3} | ZFAT | | HYAL1 | Mucopolysaccharidosis type IX | HYAL1 | | BARD1 | {Breast cancer, susceptibility to} | BARD1 | | CRBN | Mental retardation, autosomal recessive 2 | CRBN | | HCRT | Narcolepsy 1 | HCRT | | FRAS1 | Fraser syndrome | FRAS1 | | VRK1 | Pontocerebellar hypoplasia type 1A | VRK1 | | GAD1 | Cerebral palsy, spastic quadriplegic, 1 | GAD1 | | GRXCR1 | Deafness, autosomal recessive 25 | GRXCR1 | | FOXE3 | Anterior segment mesenchymal dysgenesis | FOXE3 | | FOXE3 | Aphakia, congenital primary | FOXE3 | | MHC2TA | Bare lymphocyte syndrome, type II, complementation group A | CIITA | | MHC2TA | {Rheumatoid arthritis, susceptibility to} | CIITA | | NYX | Night blindness, congenital stationary, type 1A | NYX | | KRT5 | Dowling-Degos disease | KRT5 | | KRT5 | Epidermolysis bullosa simplex with migratory circinate erythema | KRT5 | | KRT5 | Epidermolysis bullosa simplex with mottled pigmentation | KRT5 | | KRT5 | Epidermolysis bullosa simplex, Dowling-Meara type | KRT5 | | KRT5 | Epidermolysis bullosa simplex, Koebner type | KRT5 | | KRT5 | Epidermolysis bullosa simplex, Weber-Cockayne type | KRT5 | | EFEMP1 | Doyne honeycomb degeneration of retina | EFEMP1 | | PAX7 | Rhabdomyosarcoma 2, alveolar | PAX7 | | ORC4 | Meier-Gorlin syndrome 2 | ORC4 | | ZEB2 | Mowat-Wilson syndrome | ZEB2 | | NEUROD1 | Maturity-onset diabetes of the young 6 | NEUROD1 | | NEUROD1 | {Diabetes mellitus, noninsulin-dependent} | NEUROD1 | | AVP | Diabetes insipidus, neurohypophyseal | AVP | | ALDH7A1 | Epilepsy, pyridoxine-dependent | ALDH7A1 | | CSRP3 | Cardiomyopathy, dilated, 1M | CSRP3 | | CSRP3 | Cardiomyopathy, familial hypertrophic, 12 | CSRP3 | | TAF15 | Chondrosarcoma, extraskeletal myxoid | TAF15 | | GATA3 | Hypoparathyroidism, sensorineural deafness, and renal dysplasia | GATA3 | | LIPH | Hypotrichosis, localized, autosomal recessive 2 | LIPH | | LIPH | Woolly hair, autosomal recessive 2 with or without hypotrichosis | LIPH | | PRG4 | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome | PRG4 | | PLAG1 | Adenomas, salivary gland pleomorphic | PLAG1 | | MPI | Congenital disorder of glycosylation, type Ib | MPI | | KCNE2 | Atrial fibrillation, familial, 4 | KCNE2 | | KCNE2 | Long QT syndrome-6 | KCNE2 | | TNFRSF11A | Osteolysis, familial expansile | TNFRSF11A | | TNFRSF11A | Osteopetrosis, autosomal recessive 7 | TNFRSF11A | | TNFRSF11A | Paget disease of bone | TNFRSF11A | | SLC7A7 | Lysinuric protein intolerance | SLC7A7 | | GNAS | Acromegaly | GNAS | | GNAS | ACTH-independent macronodular adrenal hyperplasia | GNAS | | GNAS | McCune-Albright syndrome | GNAS | | GNAS | Osseous heteroplasia, progressive | GNAS | | GNAS | Pseudohypoparathyroidism Ia | GNAS | | GNAS | Pseudohypoparathyroidism Ib | GNAS | | GNAS | Pseudohypoparathyroidism Ic | GNAS | | GNAS | Pseudopseudohypoparathyroidism | GNAS | | IFT80 | Asphyxiating thoracic dystrophy 2 | IFT80 | | JAK2 | Leukemia, acute myelogenous | JAK2 | | JAK2 | Myelofibrosis, idiopathic | JAK2 | | JAK2 | Polycythemia vera | JAK2 | | JAK2 | Thrombocythemia 3 | JAK2 | | JAK2 | {Budd-Chiari syndrome} | JAK2 | | CYP1B1 | Glaucoma 3A, primary congenital | CYP1C1 | | CYP1B1 | Glaucoma, primary open angle, adult-onset | CYP1C1 | | CYP1B1 | Glaucoma, primary open angle, juvenile-onset | CYP1C1 | | CYP1B1 | Peters anomaly | CYP1C1 | | MAP3K1 | 46XY sex reversal 6 | MAP3K1 | | TREM2 | Nasu-Hakola disease | TREM2 | | NIPAL4 | Ichthyosis, congenital, autosomal recessive | NIPAL4 | | AK2 | Reticular dysgenesis | AK2 | | XIAP | Lymphoproliferative syndrome, X-linked, 2 | XIAP | | GUCA1A | Cone dystrophy-3 | GUCA1A | | GUCA1A | Cone-rod dystrophy 14 | GUCA1A | | SCNN1B | Bronchiectasis with or without elevated sweat chloride 1 | SCNN1B | | SCNN1B | Liddle syndrome | SCNN1B | | SCNN1B | Pseudohypoaldosteronism, type I | SCNN1B | | SCNN1B | Deafness, X-linked 1 | PRPS1 | | TRAPPC9 | Mental retardation, autosomal recessive 13 | TRAPPC9 | | HMBS | Porphyria, acute intermittent | HMBS | | HMBS | Porphyria, acute intermittent, nonerythroid variant | HMBS | | STAR | Lipoid adrenal hyperplasia | STAR | | PNLIP | Pancreatic lipase deficiency | PNLIP | | THBS2 | {Lumbar disc herniation, susceptibility to} | THBS2 | | SH3PXD2B | Frank-ter Haar syndrome | SH3PXD2B | | SAMHD1 | Aicardi-Goutieres syndrome 5 | SAMHD1 | | SAMHD1 | Chilblain lupus 2 | SAMHD1 | | HNF1A | Diabetes mellitus, insulin-dependent, 20 | HNF1A | | HNF1A | Hepatic adenoma, somatic | HNF1A | | HNF1A | MODY, type III | HNF1A | | HNF1A | Renal cell carcinoma | HNF1A | | HNF1A | {Diabetes mellitus, insulin-dependent} | HNF1A | | HNF1A | {Diabetes mellitus, noninsulin-dependent, 2} | HNF1A | | TEAD1 | Sveinsson choreoretinal atrophy | TEAD1 | | NFKBIA | Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency | NFKBIA | | RCBTB1 | {Alcohol dependence, susceptibility to} | RCBTB1 | | MEF2A | {Coronary artery disease, autosomal dominant, 1} | MEF2A | | PHGDH | Phosphoglycerate dehydrogenase deficiency | PHGDH | | PALLD | {Pancreatic cancer, susceptibility to, 1} | PALLD | | NLGN4 | Mental retardation, X-linked | NLGN4X | | NLGN4 | {Asperger syndrome susceptibility, X-linked 2} | NLGN4X | | NLGN4 | {Autism susceptibility, X-linked 2} | NLGN4X | | PDGFRB | Myeloproliferative disorder with eosinophilia | PDGFRB | | PHF6 | Borjeson-Forssman-Lehmann syndrome | PHF6 | | BTD | Biotinidase deficiency | BTD | | BMPER | Diaphanospondylodysostosis | BMPER | | KRT75 | {Pseudofolliculitis barbae, susceptibility to} | KRT75 | | STX11 | Hemophagocytic lymphohistiocytosis, familial, 4 | STX11 | | NR2E3 | Enhanced S-cone syndrome | NR2E3 | | NR2E3 | Retinitis pigmentosa 37 | NR2E3 | | ANTXR2 | Fibromatosis, juvenile hyaline | ANTXR2 | | ANTXR2 | Hyalinosis, infantile systemic | ANTXR2 | | SPINK5 | Atopy | SPIK7 | | SPINK5 | Netherton syndrome | SPIK7 | | OSMR | Amyloidosis, primary localized cutaneous, 1 | OSMR | | LRPPRC | Leigh syndrome, French-Canadian type | LRPPRC | | ANKRD26 | Thrombocytopenia 2 | ANKRD26 | | GALNT3 | Tumoral calcinosis, hyperphosphatemic, familial | GALNT3 | | KNG1 | [High molecular weight kininogen deficiency] | KNG1 | | KNG1 | [Kininogen deficiency] | KNG1 | | TMIE | Deafness, autosomal recessive 6 | TMIE | | FADD | Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malforamtions | FADD | | SGCE | Dystonia-11, myoclonic | SGCE | | RAB23 | Carpenter syndrome | RAB23 | | MMP9 | Metaphyseal anadysplasia 2 | MMP9 | | APC | Adenomatous polyposis coli | APC | | APC | Colorectal cancer, somatic | APC | | APC | Desmoid disease, hereditary | APC | | APC | Gastric cancer, somatic | APC | | APC | Hepatoblastoma, somatic | APC | | RGS9 | Bradyopsia | RGS9 | | ROBO2 | Vesicoureteral reflux 2 | ROBO2 | | RPGRIP1L | COACH syndrome | RPGRIP1L | | RPGRIP1L | Joubert syndrome 7 | RPGRIP1L | | RPGRIP1L | Meckel syndrome, type 5 | RPGRIP1L | | EPB42 | Spherocytosis, hereditary, type 5 | EPB42 | | PLIN1 | Lipodystrophy, familial partial, type 4 | PLIN1 | | PRKAG2 | Cardiomyopathy, familial hypertrophic 6 | PRKAG2 | | PRKAG2 | Glycogen storage disease of heart, lethal congenital | PRKAG2 | | PRKAG2 | Wolff-Parkinson-White syndrome | PRKAG2 | | MLPH | Griscelli syndrome, type 3 | MLPH | | PIGA | Multiple congenital anomalies-hypotonia-seizures syndrome 2 | PIGA | | PIGA | Paroxysmal nocturnal hemoglobinuria, somatic | PIGA | | CTRC | {Pancreatitis, chronic, susceptibility to} | CTRC | | EWSR1 | Ewing sarcoma | EWSR1 | | EWSR1 | Neuroepithelioma | EWSR1 | | LFNG | Spondylocostal dysostosis, autosomal recessive 3 | LFNG | | GARS | Charcot-Marie-Tooth disease, type 2D | GARS | | GARS | Neuropathy, distal hereditary motor, type V | GARS | | CAPN10 | {Diabetes mellitus, noninsulin-dependent 1} | CAPN10 | | RFXANK | MHC class II deficiency, complementation group B | RFXANK | | AKAP9 | Long QT syndrome-11 | AKAP9 | | SLC17A5 | Salla disease | SLC17A5 | | SLC17A5 | Sialic acid storage disorder, infantile | SLC17A5 | | ALG8 | Congenital disorder of glycosylation, type Ih | ALG8 | | ACAD8 | Isobutyryl-CoA dehydrogenase deficiency | ACAD8 | | ATXN7 | Spinocerebellar ataxia 7 | ATXN7 | | BLMH | {Alzheimer disease, susceptibility to} | BLMH | | C1QB | C1q deficiency | C1QB | | HMGA2 | Leiomyoma, uterine, somatic | HMGA2 | | CAV1 | Lipodystrophy, congenital generalized, type 3 | CAV1 | | PDX1 | Lacticacidemia due to PDX1 deficiency | PDHX | | PLAU | Quebec platelet disorder | PLAU | | PLAU | {Alzheimer disease, late-onset, susceptibility to} | PLAU | | COL6A3 | Bethlem myopathy | COL6A3 | | COL6A3 | Ullrich congenital muscular dystrophy | COL6A3 | | ERCC4 | Xeroderma pigmentosum, group F | ERCC4 | | ERCC4 | XFE progeroid syndrome | ERCC4 | | FH | Fumarase deficiency | FH | | FH | Leiomyomatosis and renal cell cancer | FH | | SLC52A3 | Fazio-Londe disease | SLC52A3 | | HRAS | Costello syndrome | HRAS | | RRM2B | Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy) | RRM2B | | RRM2B | Mitochondrial DNA depletion syndrome 8B (MNGIE type) | RRM2B | | SLC29A3 | Histiocytosis-lymphadenopathy plus syndrome | SLC29A3 | | FMR1 | Fragile X syndrome | FMR1 | | FMR1 | Fragile X tremor/ataxia syndrome | FMR1 | | FMR1 | Premature ovarian failure 1 | FMR1 | | SELP | {Atopy, susceptibility to} | SELP | | FSHB | Follicle-stimulating hormone deficiency, isolated | FSHB | | BRCA2 | Fanconi anemia, complementation group D1 | BRCA2 | | BRCA2 | Pancreatic cancer | BRCA2 | | BRCA2 | Prostate cancer | BRCA2 | | BRCA2 | Wilms tumor | BRCA2 | | BRCA2 | {Breast cancer, male, susceptibility to} | BRCA2 | | BRCA2 | {Breast-ovarian cancer, familial, 2} | BRCA2 | | BRCA2 | {Glioblastoma 3} | BRCA2 | | BRCA2 | {Medulloblastoma} | BRCA2 | | IL10RA | Inflammatory bowel disease 28, early onset, autosomal recessive | IL10RA | | CLN6 | Ceroid lipofuscinosis, neuronal, 6 | CLN6 | | CLN6 | Ceroid lipofuscinosis, neuronal, Kufs type, adult onset | CLN6 | | ITPR1 | Spinocerebellar ataxia 15 | ITPR1 | | COL17A1 | Epidermolysis bullosa, junctional, non-Herlitz type | COL17A1 | | KCNJ2 | Atrial fibrillation, familial, 9 | KCNJ2 | | KCNJ2 | Long QT syndrome-7 | KCNJ2 | | KCNJ2 | Short QT syndrome-3 | KCNJ2 | | SCP2 | Leukoencephalopathy with dystonia and motor neuropathy | SCP2 | | CUBN | Megaloblastic anemia-1, Finnish type | CUBN | | CHRNA3 | {Lung cancer susceptibility 2} | CHRNA3 | | CD36 | Platelet glycoprotein IV deficiency | CD36 | | CD36 | {Coronary heart disease, susceptibility to, 7} | CD36 | | CD36 | {Malaria, cerebral, reduced risk of} | CD36 |
|
|
|
